Wereables for Upper Limb Functionality in Hemiparesis
Launched by UNIVERSIDADE DA CORUÑA · Mar 7, 2025
Trial Information
Current as of April 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called "Wearables for Upper Limb Functionality in Hemiparesis," is looking to see how effective a special wearable device can be for children with unilateral cerebral palsy (UCP). The device, known as WeFun, is designed to help improve the use of an affected arm in daily activities. The study is currently recruiting children aged 3 to 8 years old who have a confirmed diagnosis of UCP and are classified as having mild to moderate manual abilities.
If your child participates in this trial, they will wear the device during daily activities and attend weekly sessions to help track progress. It's important for families to actively engage in these sessions and provide feedback, as this will help ensure the study’s success. However, if at any point the family is unable to collaborate or if the wearable device records very little activity, they may be asked to withdraw from the study. Overall, this trial aims to enhance the everyday lives of children with UCP by promoting the use of their affected arm through innovative technology.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Confirmed diagnosis of UCP.
- • Children aged between 3 and 8 years old.
- • Children rated on levels I to III on the Manual Ability Classification System (MACS).
- Exclusion Criteria:
- • Botulinum toxin injection or surgical interventions in the upper limb within 6 months prior to study entry.
- • Medical complications non-controlled that would interfere with study participation (e.g., not controlled epilepsy).
- • Predominantly athetoid or dystonia movement patterns.
- • Insufficient cognitive level to follow instructions,
- • Non-corrected marked visual impairments.
- Families can be retired from the study after starting if:
- • Families don't assist or don't collaborate in the weekly sessions with the reference person.
- • Wearable activity if presumably lower than expected (few recordings of activity, \<20%).
- • Families don't provide feedback about daily sessions through the satisfaction system in the app/registration sheet.
About Universidade Da Coruña
Universidade da Coruña is a prominent academic institution located in Spain, dedicated to advancing research and education across various disciplines, including health sciences. As a clinical trial sponsor, the university leverages its robust faculty expertise and state-of-the-art facilities to conduct innovative research aimed at improving patient outcomes and enhancing medical knowledge. With a strong commitment to ethical standards and regulatory compliance, Universidade da Coruña fosters collaboration between researchers, clinicians, and industry partners to facilitate the development of novel therapies and interventions, ultimately contributing to the betterment of public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
A Coruña, , Spain
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported